Marc Wolfgang

Vice President of Technical Development • BioNTech

Marc Wolfgang is Vice President of Technical Operations at BioNTech US, overseeing manufacture and supply chain of T-cell therapies.  Marc has over 30 years’ experience in the biotech/pharma industry, holding various positions in manufacturing, CMC, quality and regulatory affairs at Neon Therapeutics, Cerulean Pharma, Momenta Pharmaceuticals, Millennium Pharmaceuticals, Biogen and Boehringer Ingelheim Pharmaceuticals.  Marc has a B.S. degree in Biology and M.S. degree in chemistry.  He is former Chairman of the Nanomedicines Alliance and a former steering committee member for AAPS’s Nanotechnology Focus Group.

Also Speaking

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy; President, International Society for Cell & Gene Therapy • University of Pennsylvania

Chris Brown

Head of Discovery • Metagenomi

Mike Lawlor

Professor of Pathology • Medical College of Wisconsin

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.